COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 2188: Articles 21871-21880  | Next

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
Axfors, C., Schmitt, A. M., Janiaud, P., van 't Hooft, J., Abd-Elsalam, S., Abdo, E. F., Abella, B. S., Akram, J., Amaravadi, R. K., Angus, D. C., Arabi, Y. M., Azhar, S., Baden, L. R., Baker, A. W., Belkhir, L., Benfield, T., Berrevoets, M. A. H., Chen, C.-P., Chen, T.-C., Cheng, S.-H., Cheng, C.-Y., Chung, W.-S., Cohen, Y. Z., Cowan, L. N., Dalgard, O., de Almeida e Val, F. F., de Lacerda, M. V. G., de Melo, G. C., Derde, L., Dubee, V., Elfakir, A., Gordon, A. C., Hernandez-Cardenas, C. M., Hills, T., Hoepelman, A. I. M., Huang, Y.-W., Igau, B., Jin, R., Jurado-Camacho, F., Khan, K. S., Kremsner, P. G., Kreuels, B., Kuo, C.-Y., Le, T., Lin, Y.-C., Lin, W.-P., Lin, T.-H., Nakrem Lyngbakken, M., McArthur, C., McVerry, B., Meza-Meneses, P., Monteiro, W. M., Morpeth, S. C., Mourad, A., Mulligan, M. J., Murthy, S., Naggie, S., Narayanasamy, S., Nichol, A., Novack, L. A., O'Brien, S. M., Okeke, N. L., Perez, L., Perez-Padilla, R., Perrin, L., Remigio-Luna, A., Rivera-Martinez, N. E., Rockhold, F. W., Rodriguez-Llamazares, S., Rolfe, R., Rosa, R., Rosjo, H., Sampaio, V. S., Seto, T. B., Shehzad, M., Soliman, S., Stout, J. E., Thirion-Romero, I., Troxel, A. B., Tseng, T.-Y., Turner, N. A., Ulrich, R. J., Walsh, S. R., Webb, S. A., Weehuizen, J. M., Velinova, M., Wong, H.-L., Wrenn, R., Zampieri, F. G., Zhong, W., Moher, D., Goodman, S. N., Ioannidis, J. P. A., Hemkens, L. G.
10.1101/2020.09.16.20194571 — Posted: 2020-09-18 Discussion: Onsite
The impact of vital signs on the death of patients with new coronavirus pneumonia: A systematic review and meta-analysis
Du, M., Zhao, J., Yin, X., Zhang, N., Zheng, G.
10.1101/2020.09.17.20196709 — Posted: 2020-09-18
Cost-effective serological test to determine exposure to SARS-CoV-2: ELISA based on the receptor-binding domain of the spike protein (Spike-RBDN318-V510) expressed in Escherichia coli
Marquez-Ipina, A. R., Gonzalez-Gonzalez, E., Rodriguez-Sanchez, I. P., Lara-Mayorga, I. M., Mejia-Manzano, L. A., Gonzalez-Valdez, J. G., Ortiz-Lopez, R., Rojas-Martinez, A., Trujillo-de Santiago, G., Alvarez, M. M.
10.1101/2020.09.15.20195503 — Posted: 2020-09-18
Model-based and model-free characterization of epidemic outbreaks
Dehning, J., Spitzner, F. P., Linden, M. C., Mohr, S. B., Pinheiro Neto, J., Zierenberg, J., Wibral, M., Wilczek, M., Priesemann, V.
10.1101/2020.09.16.20187484 — Posted: 2020-09-18
Factors associated with the spatial heterogeneity of COVID-19 in France: a nationwide ecological study
Gaudart, J., Landier, J., huiart, l., Legendre, E., Lehot, L., Bendiane, M.-K., Chiche, L., Petitjean, A., Mosnier, E., Kirakoya-samadoulougou, F., Demongeot, J., Piarroux, R., Rebaudet, S.
10.1101/2020.09.17.20196360 — Posted: 2020-09-18
Environmental and climatic impact on the infection and mortality of SARS-CoV-2 in Peru
Samillan, V. J., Flores-Leon, D., Zutta, B. R., Rojas, E.
10.1101/2020.09.16.20196170 — Posted: 2020-09-18
Identification of potential biomarkers and inhibitors for SARS-CoV-2 infection
Gu, H., Yuan, G.
10.1101/2020.09.15.20195487 — Posted: 2020-09-18
The COVID-19 Spread in the State of Assam, India
Baruah, H. K.
10.1101/2020.09.18.20197095 — Posted: 2020-09-18
Epidemiology of SARS-CoV-2 infection in Karnataka State, South India: Transmission dynamics of symptomatic vs. asymptomatic infections
Kumar, N., Hameed, S. K. S., Babu, G. R., Venkataswamy, M. M., Dinesh, P., Kumar, P. B. G., John, D. A., Desai, A., Vasanthapuram, R.
10.1101/2020.09.17.20196501 — Posted: 2020-09-18
Multifractal behavior of SARS-CoV-2 COVID-19 pandemic spread, case of: Algeria, Russia, USA and Italy.
Ouadfeul, S.-A.
10.1101/2020.09.16.20196188 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).